C-Type Natriuretic Peptide Induces Redifferentiation of Vascular Smooth Muscle Cells With Accelerated Reendothelialization
- 1 June 2001
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (6) , 930-936
Abstract
—We recently reported that C-type natriuretic peptide (CNP) occurs in vascular endothelial cells and acts as a vascular-type natriuretic peptide. In the present study, we stimulated the cGMP cascade in proliferating smooth muscle cells (SMCs), in which particulate guanylate cyclase-B, the specific receptor for CNP, is predominantly expressed, by use of an adenovirus encoding rat CNP cDNA (Ad.CNP). In the Ad.CNP-treated cultured SMCs, CNP caused the growth inhibition of SMCs at G 1 phase with an early increase of p21 CIP1/WAF1 expression and subsequent upregulation of p16 INK4a . The expression of smooth muscle myosin heavy chain-2, which is the molecular marker of highly differentiated SMCs, was reinduced in the Ad.CNP-treated SMCs. The Ad.CNP-treated SMCs also reexpressed particulate guanylate cyclase-A, which shows high affinity to atrial and brain natriuretic peptide and is exclusively expressed in well-differentiated SMCs. CNP, which was overexpressed in rabbit femoral arteries in vivo at the time of balloon injury, significantly suppressed neointimal formation. Furthermore, an enhancement of the expression of smooth muscle myosin heavy chain-2 occurred in the residual neointima. In addition, early regeneration of endothelial cells was observed in the Ad.CNP-infected group. Thus, stimulation of cGMP cascade in proliferating dedifferentiated SMCs can induce growth inhibition and redifferentiation of SMCs with accelerated reendothelialization.Keywords
This publication has 17 references indexed in Scilit:
- Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.Journal of Clinical Investigation, 1998
- Opposite Regulation of Gax Homeobox Expression by Angiotensin II and C-Type Natriuretic PeptideHypertension, 1997
- A monoclonal antibody to C-type natriuretic peptide – preparation and application to radioimmunoassay and neutralization experimentJournal of Endocrinology, 1994
- Expression of the catalytic domain of cyclic GMP‐dependent protein kinase in a baculovirus systemFEBS Letters, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- C-Type Natriuretic Peptide Inhibits Intimal Thickening after Vascular InjuryBiochemical and Biophysical Research Communications, 1993
- Vascular natriuretic peptideThe Lancet, 1992
- Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".Journal of Clinical Investigation, 1992
- Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)Science, 1991
- Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.Journal of Clinical Investigation, 1990